Assignee
LEAP THERAPEUTICS INC
US·2 granted patents·3 pending applications·3 citations·filing 2017–2023
Top patents by PatentIndex Score
5 records- 0179US12319730B2Use of beta-catenin as a biomarker for treating cancers using anti-Dkk-1 antibodyLEAP THERAPEUTICS INC·Filed 2022·Granted Jun 3, 2025·1 cites·16 claims
- 0275US11267876B2Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibodyLEAP THERAPEUTICS INC·Filed 2017·Granted Mar 8, 2022·2 cites·13 claims
- 0357US2026077043A1Combination therapyLEAP THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0445US2024141023A1Methods of treating cancer using dkk-1 inhibitorsLEAP THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0541US2022381786A1Use of dkk-1 inhibitors for treating cancerLEAP THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LEAP THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →